Advanced in Age-Related Macular Degeneration (ARMD)

Dr. Ankoor R. Shah

Ophthalmology
Retina Consultants Of Houston PLLC
4460 Bissonnet St, Suite 200, 
Bellaire, TX 
Accepting New Patients
16 Years of Experience

Advanced in Age-Related Macular Degeneration (ARMD)
Retina Consultants Of Houston PLLC
4460 Bissonnet St, Suite 200, 
Bellaire, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ankoor Shah is an Ophthalmologist in Bellaire, Texas. Dr. Shah has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Shah is currently accepting new patients.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Age-Related Macular Degeneration (ARMD).

Graduate Year
2009
Specialties
Ophthalmology
Licenses
Ophthalmology in TX
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Card System
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

RETINA CONSULTANTS OF HOUSTON PLLC
4460 Bissonnet St, Suite 200, Bellaire, TX 77401
Call: 713-524-3434

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis BRAVOS: A Phase 1/2 Multicenter Randomized, Double Blinded, Safety Study (ITN075AI)
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Biological
Study Drug: Brentuximab vedotin
Study Phase: Phase 1/Phase 2
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Enrollment Status: Completed
Publish Date: May 24, 2021
Intervention Type: Drug
Study Phase: Phase 2
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
Enrollment Status: Completed
Publish Date: May 21, 2021
Intervention Type: Drug
Study Drug: Aflibercept Injection
Study Phase: Phase 2
A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation in Subjects With Radiation Retinopathy (RRR Study).
A Randomized, Active-Controlled, Phase II Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation in Subjects With Radiation Retinopathy (RRR Study).
Enrollment Status: Completed
Publish Date: March 25, 2021
Intervention Type: Procedure, Drug
Study Phase: Phase 2
Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)
Intravitreal Aflibercept Injection (IAI) for Radiation Retinopathy Trial (ARRT)
Enrollment Status: Unknown
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

39 Total Publications

Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the American Society of Retina Specialists.
Supply Chain Volatility of Repackaged Intravitreal Bevacizumab: A Survey of the American Society of Retina Specialists.
Journal: Journal of vitreoretinal diseases
Published: July 14, 2025
View All 39 Publications
Similar Doctors
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Charles C. Wykoff
Ophthalmology
Elite in Age-Related Macular Degeneration (ARMD)
Dr. Charles C. Wykoff
Ophthalmology

Retina Consultants Of Houston PLLC

4460 Bissonnet St, Suite 200, 
Bellaire, TX 
 (0.1 miles away)
713-524-3434
Languages Spoken:
English, Spanish, Vietnamese
See accepted insurances
Accepting New Patients

Charles Wykoff is an Ophthalmologist in Bellaire, Texas. Dr. Wykoff is rated as an Elite provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Vitrectomy, and Cataract Removal. Dr. Wykoff is currently accepting new patients.

Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Carolyn Chen
Ophthalmology
Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Carolyn Chen
Ophthalmology

Hea Clinic PA

1699 Research Forest Dr, Suite 150, 
Shenandoah, TX 
 (32.6 miles away)
281-363-2155
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Carolyn Chen is an Ophthalmologist in Shenandoah, Texas. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Choroid Plexus Carcinoma. Dr. Chen is currently accepting new patients in some locations.

Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Christina Y. Weng
Ophthalmology
Distinguished in Age-Related Macular Degeneration (ARMD)
Dr. Christina Y. Weng
Ophthalmology

Baylor College Of Medicine

1977 Butler Blvd, 
Houston, TX 
 (4.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Christina Weng is an Ophthalmologist in Houston, Texas. Dr. Weng is rated as a Distinguished provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal. Dr. Weng is currently accepting new patients.

VIEW MORE AGE-RELATED MACULAR DEGENERATION (ARMD) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shah's expertise for a condition
ConditionClose
      • Advanced
      • Age-Related Macular Degeneration (ARMD)
        Dr. Shah is
        Advanced
        . Learn about Age-Related Macular Degeneration (ARMD).
        See more Age-Related Macular Degeneration (ARMD) experts
      • Diabetic Retinopathy
        Dr. Shah is
        Advanced
        . Learn about Diabetic Retinopathy.
        See more Diabetic Retinopathy experts
      • Endophthalmitis
        Dr. Shah is
        Advanced
        . Learn about Endophthalmitis.
        See more Endophthalmitis experts
      • Late-Onset Retinal Degeneration
        Dr. Shah is
        Advanced
        . Learn about Late-Onset Retinal Degeneration.
        See more Late-Onset Retinal Degeneration experts
      • Retinal Artery Occlusion
        Dr. Shah is
        Advanced
        . Learn about Retinal Artery Occlusion.
        See more Retinal Artery Occlusion experts
      • Retinal Detachment
        Dr. Shah is
        Advanced
        . Learn about Retinal Detachment.
        See more Retinal Detachment experts
      View All 8 Advanced Conditions
      • Experienced
      • Adult-Onset Vitelliform Macular Dystrophy (AVMD)
        Dr. Shah is
        Experienced
        . Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
        See more Adult-Onset Vitelliform Macular Dystrophy (AVMD) experts
      • Cataract Removal
        Dr. Shah is
        Experienced
        . Learn about Cataract Removal.
        See more Cataract Removal experts
      • Choroid Plexus Carcinoma
        Dr. Shah is
        Experienced
        . Learn about Choroid Plexus Carcinoma.
        See more Choroid Plexus Carcinoma experts
      • Coloboma
        Dr. Shah is
        Experienced
        . Learn about Coloboma.
        See more Coloboma experts
      • Cone Dystrophy
        Dr. Shah is
        Experienced
        . Learn about Cone Dystrophy.
        See more Cone Dystrophy experts
      • Cone Rod Dystrophy Amelogenesis Imperfecta
        Dr. Shah is
        Experienced
        . Learn about Cone Rod Dystrophy Amelogenesis Imperfecta.
        See more Cone Rod Dystrophy Amelogenesis Imperfecta experts
      View All 19 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2025 All Rights Reserved